Rivastigmine Reduces “Likely to Use Methamphetamine” in Methamphetamine-Dependent Volunteers

We previously reported that treatment with the cholinesterase inhibitor rivastigmine (3 mg, PO for 5 days) significantly attenuated “Desire for METH”. Given that higher dosages of rivastigmine produce greater increases in synaptic ACh, we predicted that 6 mg should have more pronounced effects on cr...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Main Authors:	De La Garza, R., Newton, T.F., Haile, C.N., Yoon, J.H., Nerumalla, C.S., Mahoney, J.J., Aziziyeh, A.
Format:	Artigo
Sprog:	Inglês
Udgivet:	2011
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3877939/ https://ncbi.nlm.nih.gov/pubmed/22230648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pnpbp.2011.12.014
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Rivastigmine Reduces “Likely to Use Methamphetamine” in Methamphetamine-Dependent Volunteers

Lignende værker